Differences in career longevity before and after implementation of the Women's Tennis Association Tour Age Eligibility Rule and Player Development Programmes: a 25-year study.


Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
Sep 2022
Historique:
accepted: 28 03 2022
pubmed: 10 4 2022
medline: 27 8 2022
entrez: 9 4 2022
Statut: ppublish

Résumé

To assess differences in career longevity, as a potential marker of athlete well-being, before and after the 1995 implementation of the Women's Tennis Association (WTA) Age Eligibility Rule (AER) and Player Development Programmes (PDP), which focused on organisational, physical and psychosocial education, skill building and support for adolescent athletes (≤17 years). Career longevity data were collected through 2019 on adolescent players who began professional tournament play between 1970 and 2014 and reached a WTA singles ranking of 1-150 for a minimum of 1 week during their careers. Players were separated into pre-AER/PDP and post-AER/PDP groups, consisting of those who played their first professional events (FPE) before or after 1 January 1995. Measures of career longevity included career duration and premature retirement. Eight-hundred and eleven players were included in this study (51% pre-AER/PDP). The median career duration was 14.2 years for the post-AER/PDP group compared with 12.1 years for the pre-AER/PDP group (p<0.001). Moreover, post-AER/PDP players had higher probabilities of 10-year and 15-year careers compared with pre-AER/PDP players. After adjusting for age at FPE, athletes in the pre-AER/PDP group had an increased risk of shorter career duration (HR 1.55; 95% CI 1.31 to 1.83) and increased odds of premature retirement (OR 5.39; 95% CI 2.28 to 12.75) than athletes in the post-AER/PDP group. Adolescent athletes participating on the WTA after the combined AER/PDP initiative had longer career durations, higher probabilities of 10-year and 15-year careers, and decreased risk of premature retirement compared with those participating prior to AER/PDP. Organisational practices that encompass both education and competition regulation can positively affect career longevity related to improving athlete well-being.

Identifiants

pubmed: 35396204
pii: bjsports-2021-104620
doi: 10.1136/bjsports-2021-104620
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

955-960

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: AK, TL, KS and SV are employed full-time by the WTA Tour. CLO, BH, CH, NAJ, RJ, KS and AQ are all members of the WTA Player Development Advisory Panel. RJ additionally serves as a player development consultant and advisor to the WTA performance health team. SAK and EK declare no competing interests.

Auteurs

Carol L Otis (CL)

Unaffiliated, Delray Beach, Florida, USA.

Brian Hainline (B)

National Collegiate Athletic Association (NCAA), Indianapolis, Indiana, USA.

Christopher Harwood (C)

Exercise Science, Loughborough University, Loughborough, UK.

Neeru A Jayanthi (NA)

Sports Medicine Center, Emory University, Atlanta, Georgia, USA.

Rick Jensen (R)

Rick Jensen's Performance Center, Aliso Viejo, California, USA.

Ashley Keber (A)

WTA Tour, St. Petersburg, Florida, USA.

Emily Kroshus (E)

Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Center for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, Washington, USA.

Thomas Livengood (T)

WTA Tour, St. Petersburg, Florida, USA.

Kathleen Stroia (K)

WTA Tour, St. Petersburg, Florida, USA.

Ann Quinn (A)

Quintessential Edge, Blackburn, Victoria, Australia.

Sarka Vitkova (S)

WTA Tour, St. Petersburg, Florida, USA.

Stephanie A Kliethermes (SA)

Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison, Madison, Wisconsin, USA kliethermes@ortho.wisc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH